Diabetology Limited is an award winning clinical stage biopharmaceutical company employing a proprietary oral delivery system to administer known drugs as well as novel compounds to transform the treatment outcomes for patients with diabetes.
Our oral delivery technology can be applied to a broad range of APIs and we can enter into strategic partnerships and collaborative product development arrangements